Piper Sandler Just Hiked Humana Target to $254
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesPiper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Feb 2026 marks a turning point for buyers, with discounts piling up across the market. This guide breaks down where s...
Visa just posted strongest growth in years, igniting the debate about a potential stock move. This article breaks dow...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
Space-focused investors have watched Redwire stock keep dropping as headlines swirl about contracts, funding, and exe...
As NIU gears up for the (niu) 2025 earnings call, investors want clarity on future growth, margins, and strategic bet...
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
Regulators are steering crypto away from its Wild West image. This shift could unlock real advantages for XRP, from c...
New to investing? A beginner portfolio ideas for stocks and bonds can help you grow with less risk. This guide breaks...
When Paramount beat Netflix in the bid for Warner Bros. Discovery’s assets, headlines screamed victory. This piece di...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...